GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biocept Inc (FRA:B00) » Definitions » Cyclically Adjusted FCF per Share

Biocept (FRA:B00) Cyclically Adjusted FCF per Share : €-101,002.00 (As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Biocept Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Biocept's adjusted free cash flow per share for the three months ended in Jun. 2023 was €-2.833. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-101,002.00 for the trailing ten years ended in Jun. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-07), Biocept's current stock price is €6.80. Biocept's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2023 was €-101,002.00. Biocept's Cyclically Adjusted Price-to-FCF of today is .


Biocept Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Biocept's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocept Cyclically Adjusted FCF per Share Chart

Biocept Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -16,509.90 -15,068.00

Biocept Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18,593.40 -18,837.40 -15,068.00 -15,977.10 -101,002.00

Competitive Comparison of Biocept's Cyclically Adjusted FCF per Share

For the Diagnostics & Research subindustry, Biocept's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biocept's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biocept's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Biocept's Cyclically Adjusted Price-to-FCF falls into.



Biocept Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biocept's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=-2.833/128.7287*128.7287
=-2.833

Current CPI (Jun. 2023) = 128.7287.

Biocept Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201309 0.000 98.790 0.000
201312 -5,688.235 98.326 -7,447.062
201403 -21,658.824 99.695 -27,966.560
201406 -13,043.750 100.560 -16,697.627
201409 -16,631.250 100.428 -21,317.994
201412 -16,318.750 99.070 -21,204.177
201503 -3,100.000 99.621 -4,005.768
201506 -3,478.000 100.684 -4,446.773
201509 -3,348.000 100.392 -4,293.030
201512 -3,952.000 99.792 -5,097.942
201603 -3,634.000 100.470 -4,656.099
201606 -4,068.000 101.688 -5,149.751
201609 -2,700.000 101.861 -3,412.174
201612 -2,147.500 101.863 -2,713.897
201703 -1,807.500 102.862 -2,262.028
201706 -1,663.667 103.349 -2,072.216
201709 -1,531.667 104.136 -1,893.392
201712 -1,288.500 104.011 -1,594.704
201803 -761.000 105.290 -930.411
201806 -633.875 106.317 -767.498
201809 -526.444 106.507 -636.283
201812 -317.467 105.998 -385.546
201903 -141.606 107.251 -169.964
201906 -88.191 108.070 -105.050
201909 -68.610 108.329 -81.530
201912 -54.825 108.420 -65.094
202003 -18.228 108.902 -21.547
202006 -14.050 108.767 -16.629
202009 -12.894 109.815 -15.115
202012 -3.503 109.897 -4.103
202103 0.243 111.754 0.280
202106 3.414 114.631 3.834
202109 -1.384 115.734 -1.539
202112 1.537 117.630 1.682
202203 -1.664 121.301 -1.766
202206 -7.140 125.017 -7.352
202209 -7.894 125.227 -8.115
202212 -7.262 125.222 -7.465
202303 -10.000 127.348 -10.108
202306 -2.833 128.729 -2.833

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Biocept  (FRA:B00) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Biocept Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Biocept's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocept (FRA:B00) Business Description

Traded in Other Exchanges
Address
9955 Mesa Rim Road, San Diego, CA, USA, 92121
Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.

Biocept (FRA:B00) Headlines

No Headlines